Effects of radiation on the NMR relaxation effects of aqueous solutions of gadolinium contrast agents

Contrast Media and Molecular Imaging

Volumn 4, Issue 1, 2009, Pages 33-36

  Gultekin, David H ^a,b   Raidy, Thomas E ^b   Gore, John C ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Contrast agents; Radiation dose; Relaxivity; Temperature

Indexed keywords

CHELATE; CHOLINE; CONTRAST MEDIUM; CREATININE; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIDOL; INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; HETEROCYCLIC COMPOUND; N-ACETYLASPARTATE; ORGANOMETALLIC COMPOUND;

AQUEOUS SOLUTION; ARTICLE; IN VIVO STUDY; IRRADIATION; LINEAR ACCELERATOR; METABOLITE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; TEMPERATURE SENSITIVITY; CHEMISTRY; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIATION EXPOSURE; TEMPERATURE;

ASPARTIC ACID; CHOLINE; CONTRAST MEDIA; CREATINE; GADOLINIUM; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; PARTICLE ACCELERATORS; TEMPERATURE;

EID: 63449135880     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.259     Document Type: Article

References (15)

1. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J. Magn. Reson. Imag. 1999; 10: 477-484.
2. Morcos SK. Extracellular gadolinium contrast agents: differences in stability. Eur. J. Radiol. 2008; 66: 175-179.
3. Gultekin DH, Raidy TE. MRI/S of irradiated dilute aqueous solutions of gadolinium MR contrast agents. Proc. RSNA Meeting, Radiology, 2004.
4. Gultekin DH, Raidy TE, Oldham M. Radiation dose and temperature dependence of metabolite signals in proton magnetic resonance imaging and spectroscopy. Proc. AAPM 46th Meeting, Medical Physics, 2004; Vol. 31(6), 1773.
5. Weinmann HJ, Brasch RC, Press WR,Wesbey GE. Characteristics of Gd-DTPA Complex: A potential NMR contrast agent. Am. J. Radiol. 1984; 142: 619-624.
6. Tweedle MF. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest. Radiol. 1992; 27: S2-6.
7. Bloch F. Nuclear induction. Phys. Rev. 1946; 70(7-8): 460-485.
8. Hahn EL. Spin echoes. Phys. Rev. 1950; 80(4): 580-594.
9. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn. Reson. Med. 1986; 3(6): 823-833.
10. Bottomley PA. Selective volume method for performing localized NMR spectroscopy. U.S. patent no. 4,480,228, 1984.
11. Gultekin DH, Gore JC. Temperature dependence of nuclear magnetization and relaxation. J. Magn. Reson. 2005; 172(1): 133-141.
12. Gultekin DH, Gore JC. Measurement of heat transfer coefficients by nuclear magnetic resonance. Magn. Reson. Imag. 2008; 26(9): 1323-1328.
13. GE Operator Manual for Signa, Appendix F: Probe/SVQ, Document 5123076-100 Rev. 1 (10/04). General Electric Company, 2004.
14. Gore JC, Kennan RP. Contrast agents and relaxation effects. In Magnetic Resonance Imaging of the Brain and Spine, Atlas S (ed.). Chap. 5. Raven Press: New York, 1996; 89-107.
15. 1H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn. Reson. Med. 1999; 42: 1155-1158.